These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38514012)

  • 21. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.
    Weber S; Strasser K; Rath S; Kittke A; Beicht S; Alberer M; Lange-Sperandio B; Hoyer PF; Benz MR; Ponsel S; Weber LT; Klein HG; Hoefele J
    Pediatr Nephrol; 2016 Jun; 31(6):941-55. PubMed ID: 26809805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Modifiers of Mendelian Monogenic Collagen IV Nephropathies in Humans and Mice.
    Deltas C; Papagregoriou G; Louka SF; Malatras A; Flinter F; Gale DP; Gear S; Gross O; Hoefele J; Lennon R; Miner JH; Renieri A; Savige J; Turner AN
    Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digenic Alport Syndrome.
    Savige J; Renieri A; Ars E; Daga S; Pinto AM; Rothe H; Gale DP; Aksenova M; Cerkauskaite A; Bielska O; Lipska-Zietkiewicz B; Gibson JT
    Clin J Am Soc Nephrol; 2022 Nov; 17(11):1697-1706. PubMed ID: 35675912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of 27 Novel Variants in Genes
    Cerkauskaite A; Savige J; Janonyte K; Jeremiciute I; Miglinas M; Kazenaite E; Laurinavicius A; Strupaite-Sileikiene R; Vainutiene V; Burnyte B; Jankauskiene A; Rolfs A; Bauer P; Schröder S; Cerkauskiene R
    Front Med (Lausanne); 2022; 9():859521. PubMed ID: 35419377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.
    Pescucci C; Mari F; Longo I; Vogiatzi P; Caselli R; Scala E; Abaterusso C; Gusmano R; Seri M; Miglietti N; Bresin E; Renieri A
    Kidney Int; 2004 May; 65(5):1598-603. PubMed ID: 15086897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for Genetic Testing and Management of Alport Syndrome.
    Savige J; Lipska-Zietkiewicz BS; Watson E; Hertz JM; Deltas C; Mari F; Hilbert P; Plevova P; Byers P; Cerkauskaite A; Gregory M; Cerkauskiene R; Ljubanovic DG; Becherucci F; Errichiello C; Massella L; Aiello V; Lennon R; Hopkinson L; Koziell A; Lungu A; Rothe HM; Hoefele J; Zacchia M; Martic TN; Gupta A; van Eerde A; Gear S; Landini S; Palazzo V; Al-Rabadi L; Claes K; Corveleyn A; Van Hoof E; van Geel M; Williams M; Ashton E; Belge H; Ars E; Bierzynska A; Gangemi C; Renieri A; Storey H; Flinter F
    Clin J Am Soc Nephrol; 2022 Jan; 17(1):143-154. PubMed ID: 34930753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.
    Longo I; Porcedda P; Mari F; Giachino D; Meloni I; Deplano C; Brusco A; Bosio M; Massella L; Lavoratti G; Roccatello D; Frascá G; Mazzucco G; Muda AO; Conti M; Fasciolo F; Arrondel C; Heidet L; Renieri A; De Marchi M
    Kidney Int; 2002 Jun; 61(6):1947-56. PubMed ID: 12028435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel COL4A5 mutation in the proband initially diagnosed as IgAN from a Chinese family with X-linked Alport syndrome.
    Li Z; Zhu P; Huang H; Pan Y; Han P; Cui H; Kang Z; Xun M; Zhang Y; Liu S; Wang J; Wu J
    Sci China Life Sci; 2019 Dec; 62(12):1572-1579. PubMed ID: 31209800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype-Phenotype Correlations for Pathogenic
    Savige J; Huang M; Croos Dabrera MS; Shukla K; Gibson J
    Front Med (Lausanne); 2022; 9():865034. PubMed ID: 35602506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alport Syndrome: Achieving Early Diagnosis and Treatment.
    Kashtan CE
    Am J Kidney Dis; 2021 Feb; 77(2):272-279. PubMed ID: 32712016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Kidney Cysts With Progressive CKD After Radical Nephrectomy.
    Sabov M; Denic A; Mullan AF; Luehrs AC; Kline TL; Erickson BJ; Potretzke TA; Thompson RH; Sharma V; Harris PC; Rule AD
    Am J Kidney Dis; 2024 Jul; 84(1):62-72.e1. PubMed ID: 38280640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replication of genome-wide association study identified seven susceptibility genes, affirming the effect of rs2856717 on renal function and poor outcome of IgA nephropathy.
    Wang W; Li G; Hong D; Zou Y; Fei D; Wang L
    Nephrology (Carlton); 2017 Oct; 22(10):811-817. PubMed ID: 27450519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alport syndrome and Alport kidney diseases - elucidating the disease spectrum.
    Puapatanakul P; Miner JH
    Curr Opin Nephrol Hypertens; 2024 May; 33(3):283-290. PubMed ID: 38477333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering the pathogenesis of the COL4-related hematuric nephritis: A genotype/phenotype study.
    Uliana V; Sebastio P; Riva M; Carli D; Ruberto C; Bianchi L; Graziano C; Capelli I; Faletra F; Pillon R; Mattina T; Sensi A; Bonatti F; Percesepe A
    Mol Genet Genomic Med; 2021 Feb; 9(2):e1576. PubMed ID: 33369211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4).
    Jefferson JA; Lemmink HH; Hughes AE; Hill CM; Smeets HJ; Doherty CC; Maxwell AP
    Nephrol Dial Transplant; 1997 Aug; 12(8):1595-9. PubMed ID: 9269635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney Cysts in Children With Alport Syndrome: A Report of 3 Cases.
    Chang YW; Hwang DY; Chen TY; Lin CC; Tseng MH; Tsai JD
    Kidney Med; 2024 May; 6(5):100815. PubMed ID: 38680391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome.
    Vischini G; Kapp ME; Wheeler FC; Hopp L; Fogo AB
    Hum Pathol; 2018 Nov; 81():229-234. PubMed ID: 29530752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COL4A5 and LAMA5 variants co-inherited in familial hematuria: digenic inheritance or genetic modifier effect?
    Voskarides K; Papagregoriou G; Hadjipanagi D; Petrou I; Savva I; Elia A; Athanasiou Y; Pastelli A; Kkolou M; Hadjigavriel M; Stavrou C; Pierides A; Deltas C
    BMC Nephrol; 2018 May; 19(1):114. PubMed ID: 29764427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome.
    Storey H; Savige J; Sivakumar V; Abbs S; Flinter FA
    J Am Soc Nephrol; 2013 Dec; 24(12):1945-54. PubMed ID: 24052634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetic variants of familial hematuria associated genes in three families with hematuria with probands initially diagnosed as IgA nephropathy].
    Liu JW; Wang P; Huang J; Nie XJ; Zhao F; Chen LZ; Li Z; Yu ZH
    Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):674-679. PubMed ID: 31530352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.